Literature DB >> 8941641

Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats.

M Ahloulay1, M Déchaux, C Hassler, N Bouby, L Bankir.   

Abstract

The effects of glucagon (G) on proximal tubule reabsorption (PTR) and GFR seem to depend on a prior action of this hormone on the liver resulting in the liberation of a mediator and/or of a compound derived from amino acid metabolism. This study investigates in anesthetized rats the possible contribution of cAMP and urea, alone and in combination with a low dose of G, on phosphate excretion (known to depend mostly on PTR) and GFR. After a 60-min control period, cAMP (5 nmol/min x 100 grams of body weight [BW]) or urea (2.5 micromol/min x 100 grams BW) was infused intravenously for 200 min with or without G (1.2 ng/min x 100 grams BW, a physiological dose which, alone, does not influence PTR or GFR). cAMP increased markedly the excretion of phosphate and sodium (+303 and +221%, respectively, P < 0.01 for each) but did not alter GFR. Coinfusion of cAMP and G induced the same tubular effects but also induced a 20% rise in GFR (P < 0.05). Infusion of urea, with or without G, did not induce significant effects on PTR or GFR. After G infusion at increasing doses, the increase in fractional excretion of phosphate was correlated with a simultaneous rise in plasma cAMP concentration and reached a maximum for doubling of plasma cAMP. These results suggest that cAMP, normally released by the liver into the blood under the action of G, (a) is probably an essential hepatorenal link regulating the intensity of PTR, and (b) contributes, in conjunction with specific effects of G on the nephron, to the regulation of GFR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941641      PMCID: PMC507674          DOI: 10.1172/JCI119035

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  Effects of glucagon on glomerular filtration rate and urea and water excretion.

Authors:  M Ahloulay; N Bouby; F Machet; M Kubrusly; C Coutaud; L Bankir
Journal:  Am J Physiol       Date:  1992-07

2.  Inhibition by cyclic AMP and dibutyryl cyclic AMP of transport of organic acids in kidney cortex.

Authors:  R A Podevin; E F Boumendil-Podevin
Journal:  Biochim Biophys Acta       Date:  1975-01-14

3.  Role of glucagon in disposal of an amino acid load.

Authors:  G Boden; L Tappy; F Jadali; R D Hoeldtke; I Rezvani; O E Owen
Journal:  Am J Physiol       Date:  1990-08

Review 4.  Hormonal control of kidney functions at the cell level.

Authors:  F Morel; A Doucet
Journal:  Physiol Rev       Date:  1986-04       Impact factor: 37.312

5.  Influence of protein intake on renal hemodynamics and plasma hormone concentrations in normal subjects.

Authors:  J Bergström; M Ahlberg; A Alvestrand
Journal:  Acta Med Scand       Date:  1985

6.  Glucagon--how to prove its role in amino acid metabolism.

Authors:  J J Holst
Journal:  Eur J Clin Invest       Date:  1983-04       Impact factor: 4.686

7.  Glomerular filtration rate following administration of individual amino acids in conscious dogs.

Authors:  K E Lee; R A Summerill
Journal:  Q J Exp Physiol       Date:  1982-07

8.  Effect of glucagon and glomerulopressin on the renal function of the dog.

Authors:  J Uranga; R Fuenzalida; A L Rapoport; E del Castillo
Journal:  Horm Metab Res       Date:  1979-04       Impact factor: 2.936

9.  Effect of specific amino acid groups on renal hemodynamics in humans.

Authors:  P Castellino; R Levin; J Shohat; R A DeFronzo
Journal:  Am J Physiol       Date:  1990-04

10.  Effects of glucagon and PTH on the loop of Henle of rat juxtamedullary nephrons.

Authors:  J M Elalouf; N Roinel; C de Rouffignac
Journal:  Kidney Int       Date:  1986-04       Impact factor: 10.612

View more
  8 in total

Review 1.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

2.  Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C.

Authors:  Xiao C Li; Oscar A Carretero; Yuan Shao; Jia L Zhuo
Journal:  Hypertension       Date:  2006-01-03       Impact factor: 10.190

3.  Cross-talk between angiotensin II and glucagon receptor signaling mediates phosphorylation of mitogen-activated protein kinases ERK 1/2 in rat glomerular mesangial cells.

Authors:  Xiao C Li; Oscar A Carretero; Jia L Zhuo
Journal:  Biochem Pharmacol       Date:  2006-03-28       Impact factor: 5.858

4.  Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation.

Authors:  Yassine Sassi; Andrea Ahles; Dong-Jiunn Jeffery Truong; Younis Baqi; Sang-Yong Lee; Britta Husse; Jean-Sébastien Hulot; Ariana Foinquinos; Thomas Thum; Christa E Müller; Andreas Dendorfer; Bernhard Laggerbauer; Stefan Engelhardt
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

Review 5.  The cyclic AMP phenotype of fragile X and autism.

Authors:  Daniel J Kelley; Anita Bhattacharyya; Garet P Lahvis; Jerry C P Yin; Jim Malter; Richard J Davidson
Journal:  Neurosci Biobehav Rev       Date:  2008-06-17       Impact factor: 8.989

Review 6.  Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Clin Sci (Lond)       Date:  2007-08       Impact factor: 6.124

Review 7.  Recent advances in understanding integrative control of potassium homeostasis.

Authors:  Jang H Youn; Alicia A McDonough
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

8.  Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction.

Authors:  Mitsutaka Nakashima; Satoru Sakuragi; Toru Miyoshi; Shin Takayama; Tatsuto Kawaguchi; Nobuhisa Kodera; Hiroaki Akai; Yuji Koide; Hiroaki Otsuka; Tadashi Wada; Kenji Kawamoto; Machiko Tanakaya; Yusuke Katayama; Hiroshi Ito
Journal:  ESC Heart Fail       Date:  2021-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.